Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease

Marshall, 2012, Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?, Diabetologia, 55, 2301, 10.1007/s00125-012-2606-1 Williams, 2012, Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy, Diabetes, 61, 2187, 10.2337/db11-0751 Fox, 2012, Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis, Lancet, 380, 1662, 10.1016/S0140-6736(12)61350-6 International Diabetes Federation, 2014 Patterson, 2009, Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study, Lancet, 373, 2027, 10.1016/S0140-6736(09)60568-7 Zhang, 2010, Global healthcare expenditure on diabetes for 2010 and 2030, Diabetes Res Clin Pract, 87, 293, 10.1016/j.diabres.2010.01.026 Canani, 1999, Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients, Diabetes, 48, 909, 10.2337/diabetes.48.4.909 Spray, 1995, Familial risk, age at onset, and cause of end-stage renal disease in white Americans, J Am Soc Nephrol, 5, 1806, 10.1681/ASN.V5101806 U.S. Renal Data System, 2013, International comparisons 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Krolewski, 1996, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study, Kidney Int, 50, 2041, 10.1038/ki.1996.527 Fogarty, 2000, Segregation analysis of urinary albumin excretion in families with type 2 diabetes, Diabetes, 49, 1057, 10.2337/diabetes.49.6.1057 Fogarty, 2000, Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure, Kidney Int, 57, 250, 10.1046/j.1523-1755.2000.00833.x Forsblom, 1999, Heritability of albumin excretion rate in families of patients with Type II diabetes, Diabetologia, 42, 1359, 10.1007/s001250051450 Langefeld, 2004, Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus, Am J Kidney Dis, 43, 796, 10.1053/j.ajkd.2003.12.043 McKnight, 2009, Annotated chromosome maps for renal disease, Hum Mutat, 30, 314, 10.1002/humu.20885 McKnight, 2010, Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders, J Pathol, 220, 198 Pezzolesi, 2013, The genetic risk of kidney disease in type 2 diabetes, Med Clin North Am, 97, 91, 10.1016/j.mcna.2012.10.005 Thameem, 2013, A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the family investigation of nephropathy and diabetes (FIND), PLoS One, 8, e81888, 10.1371/journal.pone.0081888 Risch, 1996, The future of genetic studies of complex human diseases, Science, 273, 1516, 10.1126/science.273.5281.1516 Chan, 2014, An excess of risk-increasing low frequency variants can be a signal of polygenic inheritance in complex diseases, Am J Hum Genet, 94, 437, 10.1016/j.ajhg.2014.02.006 Sandholm, 2012, New susceptibility loci associated with kidney disease in type 1 diabetes, PLoS Genet, 8, e1002921, 10.1371/journal.pgen.1002921 Sandholm, 2014, Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes, Diabetologia, 10.1007/s00125-014-3202-3 Little, 2009, STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement, PLoS Med, 6, e22, 10.1371/journal.pmed.1000022 Shimazaki, 2005, Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy, Diabetes, 54, 1171, 10.2337/diabetes.54.4.1171 Hanson, 2010, ELMO1 variants and susceptibility to diabetic nephropathy in American Indians, Mol Genet Metab, 101, 383, 10.1016/j.ymgme.2010.08.014 Leak, 2009, Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans, Ann Hum Genet, 73, 152, 10.1111/j.1469-1809.2008.00498.x Pezzolesi, 2009, Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy, Diabetes, 58, 2698, 10.2337/db09-0641 Wu, 2013, Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population, J Endocrinol Invest, 36, 298 Yadav, 2014, Variations in CCR5, but not HFE, ELMO1, SLC12A3, are associated with susceptibility to kidney disease in North Indian subjects with type 2 diabetes, J Diabetes Saxena, 2007, Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, Science, 316, 1331, 10.1126/science.1142358 Todd, 2007, Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes, Nat Genet, 39, 857, 10.1038/ng2068 Zeggini, 2007, Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, Science, 316, 1336, 10.1126/science.1142364 Hanson, 2007, Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study, Diabetes, 56, 975, 10.2337/db06-1072 McDonough, 2011, A genome-wide association study for diabetic nephropathy genes in African Americans, Kidney Int, 79, 563, 10.1038/ki.2010.467 Franceschini, 2012, The association of genetic variants of type 2 diabetes with kidney function, Kidney Int, 82, 220, 10.1038/ki.2012.107 McKnight, 2006, A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy, J Am Soc Nephrol, 17, 831, 10.1681/ASN.2005050493 Pezzolesi, 2009, Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes, Diabetes, 58, 1403, 10.2337/db08-1514 Craig, 2009, Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes, Diabet Med, 26, 1090, 10.1111/j.1464-5491.2009.02846.x Pluzhnikov, 2010, Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughput genotyping, Am J Hum Genet, 87, 123, 10.1016/j.ajhg.2010.06.005 Veikkolainen, 2012, ErbB4 modulates tubular cell polarity and lumen diameter during kidney development, J Am Soc Nephrol, 23, 112, 10.1681/ASN.2011020160 Cooke Bailey, 2014, Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans, Hum Genet, 9, 366 Sandholm, 2013, Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes, J Am Soc Nephrol, 24, 1537, 10.1681/ASN.2012111122 Brennan, 2012, Next-generation sequencing identifies TGF-beta1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy, Biochim Biophys Acta, 1822, 589, 10.1016/j.bbadis.2012.01.008 Kelly, 2013, Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways, Physiol Genomics, 45, 710, 10.1152/physiolgenomics.00028.2013 Sun, 2010, Epigenetic histone methylation modulates fibrotic gene expression, J Am Soc Nephrol, 21, 2069, 10.1681/ASN.2010060633 Keating, 2013, Glycemic memories and the epigenetic component of diabetic nephropathy, Curr Diab Rep, 13, 574, 10.1007/s11892-013-0383-y Yuan, 2013, Involvement of p300/CBP and epigenetic histone acetylation in TGF-beta1-mediated gene transcription in mesangial cells, Am J Physiol Renal Physiol, 304, F601, 10.1152/ajprenal.00523.2012 Reddy, 2014, Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice, Kidney Int, 85, 362, 10.1038/ki.2013.387 Noh, 2009, Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury, Am J Physiol Renal Physiol, 297, F729, 10.1152/ajprenal.00086.2009 Gaikwad, 2010, Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions, Biochem J, 432, 333, 10.1042/BJ20100414 Komers, 2013, Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes, Lab Invest, 93, 543, 10.1038/labinvest.2013.47 Kato, 2007, MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors, Proc Natl Acad Sci U S A, 104, 3432, 10.1073/pnas.0611192104 Simmonds, 2013, Skewing of female X-chromosome inactivation: an epigenetic risk factor for kidney transplantation outcome, Transplantation, 95, e25, 10.1097/TP.0b013e318282256f Kato, 2012, MicroRNA circuits in transforming growth factor-beta actions and diabetic nephropathy, Semin Nephrol, 32, 253, 10.1016/j.semnephrol.2012.04.004 Zhou, 2014, Identification of novel long noncoding RNAs associated with TGF-beta/Smad3-mediated renal inflammation and fibrosis by RNA, Seq Am J Pathol, 184, 409, 10.1016/j.ajpath.2013.10.007 Bell, 2010, Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus, BMC Med Genomics, 3, 33, 10.1186/1755-8794-3-33 McCaughan, 2012, Epigenetics: time to translate into transplantation, Transplantation, 94, 1, 10.1097/TP.0b013e31824db9bd Smyth, 2014, DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease, Epigenetics, 9, 366, 10.4161/epi.27161 Sapienza, 2011, DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy, Epigenetics, 6, 20, 10.4161/epi.6.1.13362 Young, 2012, KLOTHO methylation is linked to uremic toxins and chronic kidney disease, Kidney Int, 81, 611, 10.1038/ki.2011.461 Ko, 2013, Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development, Genome Biol, 14, R108, 10.1186/gb-2013-14-10-r108 Ong, 2014, Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways, Aging Cell, 13, 142, 10.1111/acel.12159 Stenvinkel, 2007, Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?, J Intern Med, 261, 488, 10.1111/j.1365-2796.2007.01777.x Brennan, 2010, DNA methylation profiling in cell models of diabetic nephropathy, Epigenetics, 5, 396, 10.4161/epi.5.5.12077 Reinius, 2012, Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility, PLoS One, 7, e41361, 10.1371/journal.pone.0041361 Houseman, 2012, DNA methylation arrays as surrogate measures of cell mixture distribution, BMC Bioinformatics, 13, 86, 10.1186/1471-2105-13-86 Brennan, 2009, Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines, Epigenetics, 4, 159, 10.4161/epi.4.3.8793 Jacobsen, 2012, Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men, Diabetologia, 55, 3341, 10.1007/s00125-012-2717-8 McKnight, 2014, Bioinformatic resources for diabetic nephropathy, J Diabetes Bioinformatics Grassi, 2011, Genome-wide meta-analysis for severe diabetic retinopathy, Hum Mol Genet, 20, 2472, 10.1093/hmg/ddr121 Mooyaart, 2011, Genetic associations in diabetic nephropathy: a meta-analysis, Diabetologia, 54, 544, 10.1007/s00125-010-1996-1 Zhou, 2014, Association of transforming growth factor-beta1 T869C gene polymorphism with diabetic nephropathy risk, Nephrology, 19, 107, 10.1111/nep.12176 Lin, 2014, Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension–a meta-regression analysis of 98 observational studies, PLoS One, 9, e87604, 10.1371/journal.pone.0087604 Wang, 2012, Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects, J Renin Angiotensin Aldosterone Syst, 13, 161, 10.1177/1470320311417655 Yin, 2014, Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies, Metabolism, 63, 532, 10.1016/j.metabol.2013.12.008 Li, 2011, Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis, Mol Biol Rep, 38, 3243, 10.1007/s11033-010-9999-z Kang, 2012, Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy, Gene, 500, 1, 10.1016/j.gene.2012.03.056 Niu, 2012, An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy, Diabetes Res Clin Pract, 95, 110, 10.1016/j.diabres.2011.10.009 Ding, 2012, Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis, Mol Biol Rep, 39, 1293, 10.1007/s11033-011-0862-7 Maeda, 2010, Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes, Diabetes, 59, 2075, 10.2337/db10-0067 McKnight, 2010, Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis, Am J Nephrol, 32, 476, 10.1159/000321340 Zeng, 2010, A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy, Hum Genet, 127, 373, 10.1007/s00439-009-0783-x Igo, 2011, Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study, Am J Nephrol, 33, 381, 10.1159/000326763